Inhibrx Biosciences, Inc. (INBX)
79.00
+1.02
(+1.31%)
USD |
NASDAQ |
Dec 31, 16:00
79.44
+0.44
(+0.56%)
Pre-Market: 08:49
Inhibrx Biosciences Market Cap: 1.144B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 106.79M |
| Ligand Pharmaceuticals, Inc. | 3.721B |
| Armata Pharmaceuticals, Inc. | 228.15M |
| Adverum Biotechnologies, Inc. | 96.26M |
| Pelthos Therapeutics, Inc. | 20.45M |
Market Cap Related Metrics
| PS Ratio | 858.98 |
| Price to Book Value | 31.05 |
| Price | 79.00 |
| Earnings Yield | -12.96% |